New product development capabilities and the burden of ongoing R&D investment

The risk that, while requiring the ability to develop new products, market acceptance and responses to patent competition, the company must continue investing in R&D regardless of performance, and that the resulting burden or failure to achieve the expected returns on investment will affect performance.